Non-Hodgkin's Lymphoma Clinical Trials

A listing of Non-Hodgkin's Lymphoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical research study of Nivolumab and Brentuximab Vedotin for the treatment of Non-Hodgkin's Disease/Lymphomas (CheckMate 436)

Birmingham Alabama 35294

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

Birmingham Alabama 35233

A Phase 1 clinical study for patients with Lymphoma, B-Cell, Non-Hodgkin's Lymphoma

UPDATED

Birmingham Alabama 35294

A Phase 1 clinical study for patients with Non-Hodgkin Lymphoma, DLBCL, Diffuse Large B-cell Lymphoma or Grade 3 Follicular Lymphoma

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

View More ▼

Daphne Alabama 36526

A Phase 3 clinical study for patients with Follicular Lymphoma

Huntsville Alabama 35805

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

Huntsville Alabama 35805

A clinical trial to evaluate treatments using LAM-002A for patients with Lymphoma, Non-Hodgkin

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of Rituximab, Lenalidomide and Placebo to evaluate Lymphoma, Non-Hodgkin

Arizona

Gilbert Arizona 85234

A Phase 1 clinical study for patients with Lymphoma, B-Cell, Non-Hodgkin's Lymphoma

Gilbert Arizona 85234

A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

Phoenix Arizona 85259

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Phoenix Arizona 85054

A clinical trial seeking patients for a research study of EDO-S101

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

View More ▼

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of GDC-0032, letrozole and fulvestrant to evaluate Solid Cancers

UPDATED

Tucson Arizona 85710

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

Tucson Arizona 85724

A clinical research study of MT-3724 for the treatment of Non-Hodgkin's B-cell Lymphoma

Tucson Arizona 85715

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85745

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85724

A Phase 1/Phase 2 clinical study for patients with Non-Hodgkin's Lymphoma, Relapsed or Reftactory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tucson Arizona 85715

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

Arkansas

Bentonville Arkansas 72712

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Fayetteville Arkansas 72703

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Jonesboro Arkansas 72401

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

UPDATED

Little Rock Arkansas 72205

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Little Rock Arkansas 72205

A clinical trial to evaluate treatments for patients with Lymphoma, B-cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Grade 3b or Follicular Lymphoma, Grade 3b (SGN-CD19A)

California

City of Hope
Duarte California 91010

Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

View More ▼

Anaheim California 92801

A Phase 3 clinical study for patients with Follicular Lymphoma

Anaheim California 92801

A Phase 3 clinical study for patients with Follicular Lymphoma

UPDATED

Berkeley California 94704

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

Downey California 90241

A Phase 3 clinical study for patients with Follicular Lymphoma

Duarte California 91010

A clinical research study of MK-3475 for the treatment of Multiple Myeloma, Myelodysplastic Syndrome, Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Duarte California 91010

A clinical research study of romidepsin, lenalidomide and laboratory biomarker analysis, in treating patients with previously untreated Peripheral T-Cell Lymphoma

Duarte California 91010

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of B-cell Non-Hodgkin Lymphoma

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Duarte California 91010-3000

A clinical trial to evaluate treatments for patients with Lymphoma, B-cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Grade 3b or Follicular Lymphoma, Grade 3b (SGN-CD19A)

Duarte California 91010

A clinical trial to evaluate treatments using Brentuximab Vedotin, Rituximab and Bendamustine for patients with Diffuse Large B-cell Lymphoma Refractory or Follicular B-cell Non-Hodgkin's Lymphoma

Duarte California 91010

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Duarte California 91010-3000

A Phase 1 clinical study for patients with Non-Hodgkin Lymphoma, DLBCL, Diffuse Large B-cell Lymphoma or Grade 3 Follicular Lymphoma

UPDATED

Duarte California 91010-300

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Duarte California 91010

A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

Duarte California

A Phase 2 clinical study for patients with Lymphoma, Mantle-Cell, Lymphoma, Large B-Cell, Diffuse or Lymphoma, Follicular

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating BTCT4465A for the treatment of Non-Hopkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)